NCT01002781View on ClinicalTrials.gov

Efficacy and Safety of Tocilizumab in Adult's Still Disease

PHASE2UnknownINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Adult's Still Disease

Interventions

DRUG

Tocilizumab

Tocilizumab, IV, 8 mg/kg, every 2 weeks

Trial Locations (4)

64239

Tel Aviv Medical Center, Tel Aviv

Unknown

Bnei Tsion Medical Center, Haifa

Rambam Medical Center, Haifa

Assaf Harofe Medical Center, Ẕerifin

Sponsors

Collaborators (1)

Bnai Zion Medical Center

All Listed Sponsors

collaborator

Rambam Health Care Campus

OTHER

collaborator

Assaf-Harofeh Medical Center

OTHER_GOV

collaborator

Bnai Zion Medical Center

OTHER_GOV

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV